Equillium to Present at H. C. Wainwright 21st Annual Global Investment Conference

LA JOLLA, Calif., Aug. 27, 2019 (GLOBE NEWSWIRE) — Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop products to treat severe autoimmune and inflammatory disorders, today announced that Bruce Steel, Equillium?s president and chief business officer, will present at the H. C. Wainwright 21st Annual Global Investment Conference on Monday, September 9, 2019.?